STARGEN
Gene therapy and prophylaxis products, namely, proteins, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic and angiogenic molecules, all for the treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eyes; pharmaceutical preparations for treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eye; retroviral vector and retroviral vector manufacturing p...
Abandoned · August 10, 2007 · 77252613 ·